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Background: Magnolia (Magnolia officinalis) and Phellodendron (Phellodendron amurense) barks are medicinal
plants commonly used as traditional remedies for reducing stress and anxiety. Modern dietary supplements are
intended to induce relaxation and reduce stress as well as stress-related eating. Previous studies have shown the
combination of Magnolia/Phellodendron (MP) to reduce both cortisol exposure and the perception of stress/
anxiety, while improving weight loss in subjects with stress-related eating. Competitive athletes are “stressed” by
their intense exercise regimens in addition to their normal activities of daily living and thus may benefit from a
natural therapy intended to modulate baseline perceptions of stress and stress hormone exposure.
Methods: We assessed salivary cortisol exposure and psychological mood state in 56 subjects (35 men and 21
women) screened for moderate stress and supplemented with a standardized/patented MP combination
(Relora®, Next Pharmaceuticals) or Placebo for 4 weeks.
Results: After 4 weeks of supplementation, salivary cortisol exposure was significantly (p<0.05) lower (−18%) in the
Relora group compared to Placebo. Compared to Placebo, the Relora group had significantly better (p<0.05) mood
state parameters, including lower indices of Overall Stress (−11%), Tension (−13%), Depression (−20%), Anger
(−42%), Fatigue (−31%), and Confusion (−27%), and higher indices of Global Mood State (+11%) and Vigor (+18%).
Conclusion: These results indicate that daily supplementation with a combination of Magnolia bark extract and
Phellodendron bark extract (Relora®) reduces cortisol exposure and perceived daily stress, while improving a variety
of mood state parameters, including lower fatigue and higher vigor. These results suggest an effective natural
approach to modulating the detrimental health effects of chronic stress in moderately stressed adults. Future
studies should examine the possible performance and recovery benefits of Relora supplementation in athletes
overstressed by the physical and psychological demands of training and competition.
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The relationship between chronic psychological stress and
reduced health is well established [1], with psychological
stress having been shown to increase susceptibility to a
wide range of diseases including anxiety, depression,
diabetes, and obesity [2-4]. Even the “stress” of short-term
sleep loss has significant implications for long-term health
and well-being due to adverse systemic health effects* Correspondence: smtalbott@supplementwatch.com
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reproduction in any medium, provided the orincluding suppressed immune function, abdominal obesity,
insomnia, depression, and generalized fatigue [5,6].
Interventions for stress and anxiety range from nutri-
tional support to the use of antidepressant medications
such as benzodiazepines and selective serotonin reuptake
inhibitors [7,8]. A United States Patent (No. 6,582,735)
has been granted for the use of an extract of Magnolia
officinalis bark for stress related conditions involving
elevated cortisol, such as control of body weight, sleep
disturbances and restlessness [9].
Extracts of Magnolia officinalis bark and its active
constituent, honokiol, have been studied in animal modelsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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diazepine anxiolytic used to treat anxiety), but without
associated side effects such as sedation [10-13]. Berberine,
a constituent of the Phellodendron extract, has also
demonstrated a significant anxiolytic effect in rodent
stress studies, including the elevated plus maze test
and the forced swim test [14,15]. The combination of
magnolia plus phellodendron appears to be even more
effective in controlling stress/anxiety compared to either
herb used separately [16-19].
The subject of this study, Relora® (Next Pharmaceuticals,
Inc, Salinas, CA), is a proprietary dietary supplement
formulation consisting of a blend of extracts of Magnolia
officinalis bark and Phellodendron amurense bark stan-
dardized to honokiol and berberine, respectively. In
previous studies, Relora has demonstrated efficacy for
reducing stress and anxiety in animals [18,19] and enhan-
cing feelings of well-being in human subjects [20,21].
One study also measured the effects of Relora on salivary
cortisol, finding benefits in reducing cortisol and in-
creasing dehydroandrostenedione (DHEA) levels in stressed
subjects [20].
In this study, we report the effects of using the Relora
combination of magnolia bark and phellodendron bark
on salivary cortisol and psychological well-being of healthy
subjects under moderate levels of perceived psychological
stress. The current study employed a well-validated psy-
chological assessment known as the Profile of Mood States
(POMS) to assess mood state. A key objective of the study
was to explore how 4 weeks of magnolia/phellodendron
supplementation (Relora versus a placebo) affected cortisol,
various moods, and overall stress levels under conditions
of moderate psychological stress.
Methods
Dietary supplement
Relora® is a proprietary blend of a patented extract of the
bark of Magnolia officinalis and an extract of the bark of
Phellodendron amurense (US Patent Nos. 6,582,735 and
6,814,987). The product is standardized to “not less than
1.5% honokiol and 0.1% berberine.” Subjects ingested
500 mg/day at breakfast (250 mg) and dinner (250 mg) in
white opaque capsules or a look-alike placebo that was
identical in size, shape and color.
Study design
This study was done in accordance with the Helsinki
Declaration, as revised in 1983, for clinical research
involving humans and all procedures, measurements, and
informed consent processes were reviewed and approved
by an external third-party review board (Aspire IRB;
Santee, CA).
Subjects signed informed consent documents after the
study details were explained. The study used a randomizedplacebo-controlled, double-blind design. Subjects were
randomly assigned, through a random number generator,
to either 500 mg/day containing supplement (250 mg of
Relora®, consumed at breakfast and dinner) or a look-alike
Placebo (250 mg of rice flour); bottles were labeled only
with a pre-assigned random code. Subjects self-administered
the allotted capsule twice daily in the morning with break-
fast and in the evening with dinner for 4 weeks. Subjects
were contacted weekly to remind them to take their cap-
sules daily. Empty bottles were returned after the study
for a count of any unused capsules (an indicator of missed
doses). Compliance with these instructions was high
(data not shown).
We screened 60 subjects for moderate levels of psycho-
logical stress, with 56 subjects completing the study. Sixty
(60) subjects were randomized to receive Supplement
(30 subjects) or look-alike Placebo (30 subjects) for 4 weeks.
The 4-week duration was selected as more representative
of persistent changes in mood state that may result
from superior hormone balance, as opposed to short-term
changes in emotions that may be more closely linked with
stressors of daily living.
At Baseline (week 0) and Post-supplementation (week 4),
we assessed body weight and body fat percentage (Tanita
BDF-300A bioelectrical impedance analyzer), overall stress
(Yale Stress Survey), psychological mood state (Profile of
Mood States Survey) and salivary cortisol. Mood State
(Vigor, Depression, Anger, Confusion, Fatigue, and Anxiety)
was assessed using the validated Profile of Mood States
(POMS) survey [22,23]. Cortisol exposure was assessed in
pooled saliva samples collected at three time points during
each collection day (morning, afternoon, and evening).
The morning sample was collected upon waking at ap-
proximately 6am; the afternoon sample at approximately
2pm; and the evening sample immediately before bed at
approximately 10pm to represent as much of a total daily
“cortisol exposure” for each subject as possible. Cortisol
circadian rhythm data will be reported elsewhere. Sal-
iva samples were analyzed for free cortisol by enzyme
immunoassay (EIA; Salimetrics, State College, PA, USA).
Fifty-six subjects (35 men & 21 women, age 28±11 years)
completed the study, with two women in each group lost
to follow up (did not return final surveys or saliva samples).
Mood assessment
We employed the Profile Of Mood States (POMS) ques-
tionnaire, to measure 6 primary psychological factors
(tension, depression, anger, fatigue, vigor or confusion),
plus the combined “global mood state” as an indication
of subjective well-being. The POMS methodology has
been used in nearly 3,000 studies and its validity is well
established. The POMS profile uses 65 adjective-based
intensity scales scored on a 0–4 hedonic scale (0 = not
at all, 4 = extremely). The 65 adjective responses are
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anger, fatigue, vigor or confusion), tabulated, scored and
analyzed. The output of the POMS questionnaire is an
assessment of the positive and negative moods of each
subject at baseline and 4-weeks.Data management and analysis
All questionnaires were completed at a central location
and transcribed to a central database. Subjects that did
not complete the questionnaires or submitted incomplete
questionnaires were dropped from the study and not
included in the study analysis (four subjects – two females
from each group). Data was identified by subject number
and examined for accuracy and completeness. Tabulated
data was analyzed with JMP 8.0 (SAS Institute) using
standard parametric paired t-tests and significance was
assessed with a two-tailed alpha level set at 0.05.Results
Over the course of the 4-week supplementation period,
there were no adverse events or side effects reported.
There were no significant changes in body weight or body
fat percentage.
At week 4, salivary cortisol exposure was significantly
(p<0.05) lower (−18%) in the Relora group (Figure 1).
Significantly better (p<0.05) mood state indices were
observed in the Relora group for Overall Stress (−11%) and
Global Mood State (−11%) compared to Placebo (Figure 2).
Mood State subscales (Figure 3) were significantly better
(p<0.05) in the Relora group compared to Placebo at week
4; Tension (−13%), Depression (−20%), Anger (−42%),







Figure 1 Salivary Cortisol (ug/ml). Salivary cortisol was 18% lower (p<0.0
0.642+0.353).Discussion
Antidepressant drugs are the most commonly prescribed
class of medications in the United States and are used by
athletes and non-athletes alike [24]. More than 10% of the
American population is taking one or more antidepressant
drugs, which represents 27 million individuals taking more
than 120 million prescriptions and spending over $80
billion per year. According to a recent survey [25], large
numbers of Americans feel an antidepressant drug would
be helpful for; dealing with day-to-day stresses (83%);
making things easier in relations with family and friends
(76%); and helping people feel better about themselves
(68%). However, because antidepressant drugs carry the
United States Food and Drug Administration’s most
stringent “black box” warning (associated with serious
life-threatening adverse effects), there is need for safe
and effective natural approaches to reducing stress and
anxiety.
In addition to a balanced diet, regular physical activity,
and various stress management techniques, certain dietary
supplements may be effective in naturally maintaining the
normal balance between stress, cortisol, and emotional
well-being. For example, there are numerous commercial
examples of general-purpose “relaxation” and “calming”
teas based on traditional herbal blends such as chamomile,
fennel, lemon balm and others, while magnolia and
phellodendron bark extracts have been specifically dem-
onstrated as natural anxiolytic agents, [7-21,26]. As such,
appropriate dietary supplements may be a safe and effect-
ive natural adjunct to diet/exercise/stress management
techniques to bring stress response and cortisol levels
back to within normal ranges in individuals suffering from





















Figure 2 Global Mood State (POMS) and Overall Stress (Yale Stress Survey). Global Mood State was 11% better (p<0.05) in the Relora group
compared to Placebo (118+18 to 133+30) – lower score is a “better” Global Mood State (POMS). Overall Stress (Yale Stress Survey) was 11% lower
(p<0.05) in the Relora group compared to Placebo (30.2+5.2 to 33.9+7.4). The global mood state was calculated based on scoring (0-4 with
0 = not at all, 2 = moderately and 4 = extremely) answers to 58 of the 65 adjectives of the POMS (a lower number is a “better” global mood state).
Global Mood State is the combined score of the 6 subscales of the POMS (McNair et al., [9]).
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bark (Phellodendron amurense) are traditional herbal med-
icines used since 100A.D. for treating “stagnation of Qi” in
Chinese medicine [7,8,17], which is analogous to what we
view in Western medicine as reduced psychological vigor
or burnout. Magnolia bark extracts are rich in the
phenolic compound, honokiol [12], while Phellodendron
bark extracts are rich in berberine [14,15] – each of which
contributes to the primary anti-stress, anti-anxiety, and
cortisol-lowering effects of the plants [9-19,26]. Research
has shown magnolia and phellodendron extracts and
















Figure 3 Profile of Mood States (POMS). Numerical scores for each of th
showed significantly improved mood state parameters compared to Placebpossess powerful “mental acuity” benefits [10,11,16] via
their actions in modulating the activity of various neuro-
transmitters and related enzymes in the brain, including
brain-derived neurotrophic factor, acetylcholine, choline
acetyltransferase, and acetylcholinesterase.
Numerous animal studies have demonstrated that
honokiol and berberine act as anxiolytic agents [9-19,26].
When compared to pharmaceutical agents such as Valium
(diazepam), honokiol and berberine appear to be as effect-
ive in their anti-anxiety activity yet not nearly as powerful
in their sedative ability [9,12,13]. These results have been








e 6 subscales of the POMS (McNair et al., [9]). The Relora group
o at Week 4 (* = p<0,05).
Talbott et al. Journal of the International Society of Sports Nutrition 2013, 10:37 Page 5 of 6
http://www.jissn.com/content/10/1/37Relora, which is standardized to both honokiol (from
magnolia bark) and berberine (from phellodendron), is an
effective natural approach for controlling the detrimental
effects of everyday stressors, without the tranquilizing side
effects of pharmaceutical agents [14-19,26]. Previous
human studies on Relora have shown similar anti-stress
and anxiolytic benefits in moderately stressed subjects
[20,21]. The results reported in this study expand on pre-
vious findings of simple “relaxation” benefits of Relora to
demonstrate specific effects on psychological mood state
parameters in moderately-stressed subjects, including ben-
efits for Global Mood State (analogous to an assessment
of overall well-being), Tension, Depression, Fatigue, and
Vigor (the opposite psychological state from “Burnout”).
The magnitude of benefit in stress hormone (cortisol)
reduction (18%) and mood state improvement (11%-42%)
is meaningful from the perspective of optimal mental and
physical performance. For example, the 18% higher Vigor
or the 20% lower Depression score observed in the Relora
group, could reasonably be associated with subjects
reporting “feeling good” (in the case on our moderately-
stressed subjects) or “performing well” (in the case of
over-stressed or over-trained athletes, which should be the
subject of future studies).
Although our study was not conducted in competitive
athletes, a number of our moderately stressed healthy
subjects were recreational runners and cyclists who com-
mented about feeling more “balanced” in their workouts
when their stress levels were balanced. This is a logical
individual perception based on a number of studies in
elite-level and recreational athletes that have found a
direct relationship between overall stress (physical training
and psychological stress) and athletic performance, includ-
ing both mental and physical performance parameters
[27-31]. Competitive athletes tend to be characterized by
an elevated Vigor score and lower Fatigue score compared
to non-athletes [27]. However, in many intervention
studies of athletes, a dose–response exists between training
stress and mood state [28,29], so as overall physical
“training stress” is elevated beyond a certain tipping
point, psychological mood state becomes depressed. In
addition, low Vigor scores and overall reduced psycho-
logical mood state have been identified as predictors of
future athletic injury [30]. The most dramatic changes
in psychological mood state are logically the result of
intensified periods of training (e.g. increased training
intensity and/or duration), which can be modulated
positively or negatively by psychological stress (e.g. exams),
competitive anxiety, social support network, sleep patterns,
and recovery methods [27-31]. Based on the magnitude
of the positive changes in cortisol levels and mood state
parameters, we would recommend further athlete-specific
studies to gauge the possible mental/physical performance
benefits of Relora in enhancing post-exercise recoveryand preventing over-training syndrome in competitive
athletes.
Results from the current study indicate that daily
supplementation with a combination of magnolia bark
and phellodendron bark (Relora) reduces cortisol exposure
and perceived stress, while improving a variety of mood
state parameters. Compared to the Placebo group, salivary
cortisol exposure was significantly lower (−18%) in the
Relora group, while mood state parameters were signifi-
cantly and meaningfully higher, including an 11% superior
Global Mood State and 18% higher Vigor, with 13% lower
Tension and 20% lower Depression indices. These results
indicate that daily supplementation with a combination
of Magnolia and Phellodendron (Relora) is an effective
natural approach to the detrimental health effects of
chronic stress.
Conclusions
The present study indicates a significant “anti-stress” bene-
fit of magnolia/phellodendron bark (Relora) supplementa-
tion in moderately stressed non-athletes, and suggests a
possible benefit for athletes to recover from “training
stress” induced by the physical and psychological demands
of competition and training. Future studies should examine
the potential benefits of Relora in helping athletes to en-
hance post-exercise recovery and possibly to help prevent
overtraining syndrome.
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